+
Site Tour

Debate: Factor XI inhibitors are far away H.C. Diener

13th Annual International Left Atrial Appendage Occlusion (LAAO) Summit - Debate: Factor XI inhibitors are far away by Hans-Christoph Diener

LEARN MORE:

LAAO Summit 2024

Related Videos

LAAO Summit - Imaging debate: TEE

LAAO Summit - Decoding DRT patient factors

LAAO Summit - The right antithrombotic regimen

LAAO Summit - Mastering leaks

PremiClose 2024: Pediatric cardiologist view

ESC 2023 Tutorial – TriClip™ | Prof. Donal

AV Valves Summit 2024 | Closing of Day 1

EACVI Summit 2023: Congress symposium

Screening Transmission | Mitral focus

ESC 2023 Tutorial – TriClip™ | Dr. Sanchis

LAAO Summit 2023: Stroke severity

LAAO Summit 2023: ICE

TRENDING TOPICS

AV Valves Summit 2024 | Opening of Day 2

AV Valves Summit 2024 | Opening of Day 2

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

AV Valves Summit 2024 | Closing of Day 1

AV Valves Summit 2024 | Closing of Day 1

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

Case Parade | Tricuspid focus

Case Parade | Tricuspid focus

M. Sitges, R. Estevez, V. Ninios, E. L. Heng, X. Freixa, W. Wojakowski, C. Besler

CONNEXT


TV
RELATED RESOURCES

LAAO Summit 2022: TEE

LAAO Summit 2022: Panel discussion – Session 1

T-TEER: echo procedural approach

LAAO in ESKD patients

CONNEXT


HUB
RELATED RESOURCES

LAAO Patient Guide

ESOC 2022 PFO: FAQ

PFO Neuro Brochure

Clinical insights: Intaglio™

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline